Product Description
Overall, the global hemostasis device market was valued at nearly $716 million in 2025. This is expected to increase over the forecast period at a CAGR of 4.0% to reach nearly $945 million.
The full report suite on the global market for hemostasis devices includes hemostasis probes, ligation devices, sclerotherapy needles and hemostasis powder.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers,
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Hemostasis Device Market Trends

Therapies that combine sclerotherapy needles with other hemostasis devices, such as ligation clips or electrosurgical probes, have demonstrated higher effectiveness compared to single-device procedures. Because both physicians and patients seek to reduce the likelihood of requiring repeat treatments, the adoption of these combination therapies is expected to rise. This trend will have a positive impact on unit sales growth.
Global Hemostasis Device Market Share Insights

- Boston Scientific was the leading competitor in the hemostasis device market in 2025, maintaining share across all major segments. Following the launch of the Resolution 360™ ligation clip in 2016, the company expanded its portfolio with the Resolution 360™ ULTRA in 2020, further strengthening its leadership position. In addition, Boston Scientific markets its Gold Probe™ devices as its flagship hemostasis probes.
- Olympus was the second-leading competitor in the hemostasis device market in 2025. The company’s overall position is strongly anchored by its share in the ligation device segment. Notably, Olympus is also the sole competitor in the heat probe market, where it offers its HeatProbes™ product line.
- Cook Medical was the third-leading competitor in the hemostasis device market in 2025. Its portfolio is led by the 6 Shooter® Universal Saeed® Multi-Ligator, while the company also maintains a modest presence in the ligation clip, electrosurgical probe and sclerotherapy needle segments.
Global Hemostasis Device Market Segmentation Summary
- Hemostasis Probe Market
- Ligation Device Market
- Sclerotherapy Needle Market
- Hemostasis Powder Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.